JOSEPH ANDERSON: Open Payments
NPI 1386699833 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 47 payments from 12 companies in 2025. Trend: 2023 $1,070 · 2024 $984 · 2025 $1,143
Food & beverage: $838Education: $305
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $372 |
| Novartis Pharmaceuticals Corporation | 14 | $265 |
| ABBVIE INC. | 11 | $203 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $94 |
| LEO Pharma Inc. | 2 | $50 |
| UCB, Inc. | 2 | $47 |
| Incyte Corporation | 2 | $32 |
| Lilly USA, LLC | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
Products named: TREMFYA, COSENTYX, SKYRIZI, SPEVIGO, Bimzelx, OPZELURA, EBGLYSS, ADBRY.
Industry payments across ID — which companies pay providers there.
